Archives

Please join Novum’s Chief Scientific Officer Dr. Keith Gallicano at the inaugural workshop for Scientists Advancing Affordable Medicines, Inc.

Posted on September 11, 2018 by Andrea

The Association for Accessible Medicines (AAM) invited Dr. Keith D. Gallicano, Novum’s Chief Scientific Officer to be a panelist at the GRx +Biosims Conference on September 5-7, 2018 in Baltimore, MD.

Posted on August 31, 2018 by imagebox

Dr. Keith D. Gallicano, Novum’s Chief Scientific Officer published in March 2018 his 4th edition of the book chapter on Design and Data Analysis in Drug Interaction Studies.

Posted on May 15, 2018 by imagebox

Novum’s Scientific leadership published a paper on Relative Bioavailability of a Single 4-mg Dose of Somatropin Administered by Subcutaneous Injection or by Needle-free Device and Coadministered With the Growth Hormone Inhibitor Octreotide Acetate.

Posted on May 10, 2018 by Andrea

Dr. Keith D. Gallicano was invited to present at the Global Bioequivalence Harmonization Initiative (GBHI) 3rd International Conference in Amsterdam on April 12-13, 2018.

Posted on May 9, 2018 by imagebox

Novum Conduct of Opioid Abuse Deterrent Studies

Posted on January 10, 2018 by imagebox

Novum’s Scientific Leadership Presented Transdermal Poster at AAPS 2017 on November 13th at 1 pm.

Posted on November 2, 2017 by imagebox

Keith D. Gallicano Was Invited to be a Panelist at The 2017 Association for Accessible Medicines (AAM) Fall Technical Conference

Posted on October 26, 2017 by imagebox

Novum Expands, Upgrades Las Vegas Clinical Facility

Posted on October 12, 2017 by imagebox

Pina D’ Angelo was invited to be a panelist at The 2017 ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

Posted on September 18, 2017 by imagebox